Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
VLEKT is characterized by a very low total energy intake (650800 kcal per day), carbohydrate restriction to less than 30 g/day, fat intake of around 20 g/day with a preference for sources of unsaturated fats such as extra-virgin olive oil, and protein intake of 0.81.2 g/kg of reference body weight (i.e., calculated based on the patient's height) ( MAD was developed in 2003 as an alternative to the conventional KD, particularly in the context of treating drug-resistant epilepsy ( MCTKD was developed in 1971 by Huttenlocher et al
Entry-level quantity format for controlled research applications
GLP-1 receptor agonists, SGLT2 inhibitors and DPP-4 inhibitors GLP-1 receptor agonists, sodium glucose co-transporter-2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors reduce the risk of MACE compared to placebo
doi: 10.3389/fneur.2022.844697 27
Example Calculation Consider a 2000mAh (2Ah) LiPo battery: 1C discharge = 2A, which means the battery would theoretically last 1 hour
US$ 22.43
US$ 28.76
US$ 22.53
US$ 28.38
